Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07213492

Multimodal Intervention to Support Hospital-to-Community Transition in Bipolar Disorder

People with bipolar disorder (BD) are at high risk of relapse following hospital discharge, partly due to a lack of BD-specific expertise and resources within community services required for comprehensive treatment. Although clinical guidelines recommend combining medication and psychosocial support, and research shows that early intervention is associated with improved outcomes, no structured care programs currently exist for individuals in the early stages of BD, contributing to chronic illness progression and preventable hospitalizations. This open-label pilot trial will assess the feasibility, acceptability, and preliminary effectiveness of a structured care pathway to support the transition from hospital to community care. The intervention includes group-based psychoeducation, individual peer support, and personalized support for community healthcare providers to improve illness insight, treatment adherence, and symptom management.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–35 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

St. Joseph's Healthcare Hamilton

Hamilton, Ontario, L8N 3K7, Canada

Location status: Recruiting

Location contact

Daniela Giansante, MSc

CONTACT

[email protected]

Fabiano A. Gomes, MD, Ph.D.

CONTACT

[email protected]

905-522-1155 ext. 39520

Fabiano A. Gomes, MD, Ph.D.

PRINCIPAL_INVESTIGATOR

About this study

This is a 6-month, open-label pilot study of the feasibility, acceptability, and preliminary effectiveness of a multimodal transitional-care intervention for individuals with BD who have recently been discharged from the hospital. The intervention comprises a brief group psychoeducation program (6 clinician-facilitated sessions delivered over up to 8 weeks), individualized peer support (biweekly one-on-one sessions for ~12 total across 6 months), and optional personalized support for participants' primary healthcare providers (two collaborative sessions over 6 months offering guideline-based recommendations and access/training to a clinical decision-support app). Ten patient-participants who meet the inclusion criteria will be enrolled over 6 months; this sample will be used to estimate recruitment, retention, adherence, satisfaction, and safety parameters, and to inform power and procedures for a subsequent randomized controlled trial. Participants will be recruited from St. Joseph's Healthcare Hamilton (SJHH) outpatient clinics, the community and the ENABLE research registry at SJHH (Hamilton, ON, Canada). Eligible adults are 18-35 years old with a BD diagnosis within the past 24 months and a history of psychosis and/or limited illness insight; all must meet inclusion/exclusion criteria and provide written informed consent. After obtaining consent, eligibility will be confirmed with the Mini-International Neuropsychiatric Interview (MINI) and the Mood Disorders Insight Scale (MDIS). Study visits occur at three timepoints: baseline, post-psychoeducation, and post-multimodal intervention (6 months). At each assessment time point, clinicians and/or patient-participants will complete validated measures; socio-demographic and clinical history will be collected at baseline. Feasibility will be assessed through recruitment, enrollment, adherence (session attendance/completion), and retention metrics; acceptability through patient-participant and healthcare-provider satisfaction questionnaires; and safety through prospective monitoring of emergent symptoms, acute relapse, emergency visits, hospitalizations, and suicide-related events. Data will be summarized primarily with descriptive statistics (means, standard deviations, frequencies); exploratory pre-post comparisons (e.g., t-tests or chi-square) will evaluate the signal of change in symptoms, insight, functioning, lifestyle, and quality of life. The results of this study will determine whether delivering a structured psychoeducation + peer-support + provider-support care pathway during the transition from hospital to community is feasible and acceptable for early-stage BD, and will guide sample-size calculations, procedures, and implementation strategies for a subsequent randomized controlled trial.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age: Patient-participants must be between 18 and 35 years old.
  • Diagnosis: Must have been diagnosed with bipolar disorder within the past 24 months.
  • Clinical Features: Must have experienced psychosis and/or a lack of insight into their illness at the time of enrollment.
  • Language Proficiency: Must be able to understand and speak English.

Exclusion criteria

  • Severe Psychiatric Conditions: Individuals with a severe psychiatric condition that would prevent them from safely engaging in the intervention.
  • Cognitive or Medical Impairment: Those with significant cognitive impairment or a medical condition that interferes with their ability to participate in psychoeducation or peer-support sessions.
  • Substance Use Disorder: Individuals with an active substance use disorder that may impact adherence to the intervention.
  • Language Barriers: Participants who do not speak English and are unable to engage in study sessions without language support.
  • Concurrent Participation in Similar Programs: Individuals who are already enrolled in another structured psychoeducational or peer-support program that could interfere with study outcomes.

Treatment and study plan

Group-Based Psychoeducation

Behavioral

Participants attend a six-session, group-based psychoeducation program delivered over 8 weeks. Sessions focus on improving insight into bipolar disorder, relapse prevention, lifestyle strategies (e.g., sleep, nutrition, substance use), and digital literacy. The aim is to enhance understanding of illness and support long-term functioning.

Peer Support

Behavioral

Trained peer support workers provide biweekly sessions over 6 months to participants. The sessions are based on the CANMAT/ISBD Patient and Family Guide and include emotional support, psychoeducation, and shared experience. Each participant receives up to 12 sessions aimed at improving engagement and understanding of illness.

Personalized Support for Community Healthcare Provider

Behavioral

The research team provides two personalized support sessions over 6 months to each participant's healthcare provider (e.g., family doctor or psychiatrist). Support includes treatment recommendations based on the CANMAT/ISBD 2018 Guidelines and training on the C-IMPACT BD web-based clinical decision support tool.

Primary outcomes

  1. Feasibility of the Multi-Modal Transitional Care Intervention

    Time frame: From enrollment to the end of intervention at 6 months.

    Feasibility will be assessed using three descriptive indicators: 1) Recruitment rate: the proportion of eligible patient-participants and community healthcare providers who consent to participate. 2) Retention rate: the proportion of enrolled participants who remain in the study until the final follow-up. 3) Intervention adherence: participant adherence to each intervention component, including the number of sessions attended and number of dropouts.

    Each indicator will be analyzed separately to determine the feasibility of implementing the multi-modal transitional care intervention.

  2. Acceptability of the Multi-Modal Transitional Care Intervention

    Time frame: Administered at the end of the intervention (Month 6).

    Acceptability will be measured using post-intervention surveys completed by patient-participants and community healthcare providers. Surveys will assess satisfaction and perceived usefulness of the intervention using Likert-scale items, with the option to provide additional information via open-ended questions.

Secondary outcomes

  1. Change in Depression Symptoms (MADRS)

    Time frame: Baseline and Month 6 (end of intervention).

    Clinician-rated 10-item scale assessing depressive symptoms over the past 7 days. Items are rated on a 7-point Likert scale, with higher scores indicating more severe symptoms.

  2. Change in Mania Symptoms (YMRS)

    Time frame: Baseline and Month 6 (end of intervention).

    Clinician-rated 11-item scale assessing manic symptoms using clinical interview and observation. Items scored 0-4 or 0-8, with higher scores indicating more severe mania.

  3. Change in Anxiety Symptoms (GAD-7)

    Time frame: Baseline, Mid-intervention (Month 3), and Month 6 (end of intervention).

    7-item self-report scale assessing anxiety over the past 2 weeks. Items scored 0-3; higher scores reflect greater anxiety.

  4. Change in Depression Severity (Patient Health Questionnaire) (PHQ-9)

    Time frame: Baseline, Mid-intervention (Month 3), and Month 6 (end of intervention).

    9-item self-report scale evaluating the presence and severity of depression symptoms over the past 2 weeks. Each item scored 0-3; higher scores indicate greater severity.

  5. Change in Insight (MDIS)

    Time frame: Baseline and Month 6 (end of intervention).

    Self-report scale assessing insight in mood disorders. Participants respond "Agree," "Disagree," or "Unsure." Higher scores indicate better insight.

  6. Change in Psychosocial Functioning (FAST)

    Time frame: Baseline and Month 6 (end of intervention).

    Clinician-administered scale assessing functioning across six domains (autonomy, work, cognition, finances, relationships, leisure). Each item rated 0-3.

  7. Change in Cognitive Complaints (COBRA)

    Time frame: Baseline and Month 6 (end of intervention).

    16-item self-report questionnaire measuring cognitive dysfunction in bipolar disorder. Each item scored 0-3; higher scores indicate more impairment.

  8. Change in Quality of Life (Q-LES-Q-SF)

    Time frame: Baseline, Mid-intervention (Month 3), and Month 6 (end of intervention).

    16-item self-report scale assessing satisfaction and enjoyment in multiple life areas over the past week. Items rated on a 5-point scale.

  9. Change in Lifestyle Behaviours (SMILE)

    Time frame: Baseline and Month 6 (end of intervention).

    Self-report scale measuring behaviours across seven lifestyle domains (diet and nutrition, substance use, physical activity, stress management, restorative sleep, social support, and environmental exposures). Items scored on a 4-point scale; higher scores reflect healthier lifestyle.

Other outcomes

  1. Safety Monitoring: Relapse, Hospitalization, and Risk

    Time frame: Throughout the 6-month intervention period.

    Monitoring and documentation of adverse events including psychiatric relapse, hospitalizations, and suicide attempts throughout the intervention period.

  2. Sociodemographic Factors

    Time frame: Baseline and Month 6 (end of intervention).

    Demographic and clinical background data will be collected, including gender, age, ethnicity, marital status, education level, income, medical and psychiatric history, family history of psychiatric disorders, medication usage, and treatment history.

Study contacts

Contact information is provided by the study sponsor or research team.

Daniela Giansante, MSc

CONTACT

[email protected]

Fabiano A. Gomes, MD, Ph.D.

CONTACT

[email protected]

905-522-1155 ext. 39520

Sponsors and collaborators

Lead sponsor

McMaster University

Other

Collaborators

  • St. Joseph's Healthcare Hamilton

Registry information

Official study title

A Bridge to Better Days: A Pilot Study of a Multimodal Intervention to Support the Successful Transition From Hospital to Community Care for People Living With Bipolar Disorder

Acronym: BTBD

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Oct 9, 2025
Registry last updated
Jan 14, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.